Our Researcher
Dr. Mark Basik
Among many important research initiatives, Dr. Basik and his team are focused on better understanding drug-resistant cells. While breast cancer is commonly treated with a variety of therapies, including chemotherapy and radiation, not all cancerous cells are destroyed using these methods. If cells are not destroyed, the disease can continue to wreak havoc in the body. Figuring out why some cells are resistant to certain breast cancer therapies is an important step in finding a cure.
Dr. Mark Basik
McGill Centre for Translational Research in Cancer Senior Investigator, Lady Davis Institute for Medical Research
Associate Professor, Departments of Surgery and Oncology, McGill University
Related Researchers
Providing financial support for breast cancer research has always been a driving force in CURE’s mission. Through strategic partnerships with Canada’s top institutions, the foundation invests in basic, translational and clinical research, all with the goal of improving treatment and finding a cure.
Dr. Mark Clemons
Clinical Investigator at the Ottawa Hospital Research Institute (Cancer Therapeutics Program), staff medical oncologist (Ottawa Hospital Cancer Centre) and Professor of Medicine (University of Ottawa)
Centre de recherche du CHU de Québec : Université Laval, in partnership with Cancer Research Society
Our Researchers & Funding Partners
Providing financial support for breast cancer research has always been a driving force in CURE’s mission. Through strategic partnerships with Canada’s top institutions, the foundation invests in basic, translational and clinical research, all with the goal of improving treatment and finding a cure.
